Tata Chemicals Limited (TCL), a prominent company known for sustainable, science-based chemistry solutions, has entered into a Memorandum of Understanding (MoU) with Bharatiya Sanskriti Darshan Trust (BSDT) and its Integrated Cancer Treatment and Research Centre (ICTRC) in Pune. This partnership will explore the potential health benefits of TCL’s prebiotic, soluble dietary fibers and their derivatives, focusing on gut health and overall well-being. The collaboration reflects both Tata Chemicals and BSDT’s shared dedication to advancing nutrition solutions grounded in scientific research to improve quality of life.
The MoU was signed with Tata Chemicals’ R&D team, led by DR Richard Lobo, and the BSDT team, led by Dr Sushrut S. Sardeshmukh, Trustee, BSDT, and Dr Vineeta V. Deshmukh, Deputy Director, ICTRC. The collaboration will combine scientific research with Ayurvedic principles to create innovative health and wellness solutions.
Dr Richard Lobo, Head of Innovation, R&D, and Chief Ethics Counsellor at Tata Chemicals, expressed his excitement about the partnership, saying, “This is a pivotal moment for us, as the mission and values of BSDT’s Integrated Cancer Treatment and Research Centre closely align with Tata Chemicals. We are eager to collaborate to enhance the functionality of our science-based products in Ayurvedic formulations, aiming to improve lives and relieve pain through Ayurvedic practices.”
Dr Sushrut S. Sardeshmukh, Trustee at Bharatiya Sanskriti Darshan Trust, remarked, “We are delighted to partner with Tata Chemicals. At BSDT, we have always focused on integrating Ayurveda with modern science to enhance patient care and quality of life. This collaboration represents a significant step in advancing Ayurvedic wellness products with scientific innovation. By combining BSDT’s expertise in holistic healing and Tata Chemicals’ commitment to product innovation, we look forward to exploring solutions that promote overall well-being.”
BSDT, with its deep knowledge of Ayurveda, has helped improve the lives of thousands of cancer patients. By merging Tata Chemicals’ nature-driven products with BSDT’s traditional healing methods, the collaboration aims to push forward advancements in nutritional science and holistic wellness, developing solutions that blend traditional and modern healthcare practices.
Founded in 1954, Bharatiya Sanskriti Darshan Trust integrates the ancient wisdom of Indian Ayurveda to treat cancer and other critical illnesses alongside modern medical practices. The founder, Reverend Parampoojya P. K. Sardeshmukh Maharaj, is a recognized authority on Indian traditional sciences. BSDT’s Cancer Research Project at the Ayurved Hospital & Research Centre, operating since 1994, has treated over 12,000 cancer patients using a unique blend of traditional Indian methods and modern science.
A subsidiary of the US$ 165 billion Tata Group, Tata Chemicals Limited is a leading supplier to various industries, including glass, detergent, and chemicals. The company also holds a strong position in the crop protection sector through its subsidiary, Rallis India Limited. Tata Chemicals operates world-class R&D facilities in Pune and Bangalore.
